full

Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

About the Podcast

Show artwork for Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
A Research To Practice Podcast for Oncology Clinicians

Listen for free